<p>在過去的 7 天裏，美國市場上漲了 2.8%，在過去 12 個月中上漲了 9.3%，預計年收益將增長 14%。在這樣的環境下，識別財務狀況良好的股票對於尋求價值和增長潛力的投資者來説變得至關重要。雖然便士股票由於其較小的規模或較新的狀態常被視為小眾，但當它們展現出強健的財務健康和長期前景時，仍然可以提供獨特的機會。</p>
<h3>美國十大便士股票</h3>
<table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.45</td>
<td>$361.71M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.39</td>
<td>$1.44B</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Perfect (NYSE:PERF)</td>
<td>$1.86</td>
<td>$189.44M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.05</td>
<td>$18.66M</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.315</td>
<td>$9.95M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.65</td>
<td>$46.16M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Imperial Petroleum (NasdaqCM:IMPP)</td>
<td>$2.56</td>
<td>$77.65M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8294</td>
<td>$6.02M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.594</td>
<td>$80.24M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.7957</td>
<td>$71.73M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
<p>點擊這裏查看我們美國便士股票篩選器的 748 只股票完整列表。</p>
<p>我們將查看篩選工具中一些最佳選擇。</p>
<h2>Blade Air Mobility (NasdaqCM:BLDE)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
<p><strong>概述：</strong> Blade Air Mobility, Inc. 提供美國及國際醫院的空中運輸和物流服務，市值為 2.3427 億美元。</p>
<p><strong>運營：</strong> 該公司主要通過兩個部門產生收入：醫療服務貢獻了 1.4682 億美元，乘客服務帶來了 1.0188 億美元。</p>
<p><strong>市值：</strong> 2.3427 億美元</p>
<p>儘管目前處於虧損狀態，Blade Air Mobility, Inc. 仍展現出韌性，2024 年淨虧損為 2731 萬美元，較去年 5608 萬美元的虧損有所改善。該公司享有強健的財務狀況，沒有債務，短期資產為 1.607 億美元，遠超負債，為基於自由現金流提供了超過三年的現金流。近期的舉措包括與 Skyports Infrastructure 合作的試點項目，旨在擴大紐約市的城市空中出行服務，可能增強未來的收入來源和運營效率，隨着其向電動垂直起降飛機的過渡。</p>
<ul>
<li>在這裏深入瞭解 Blade Air Mobility 的具體情況，查看我們的詳細資產負債表健康報告。</li>
<li>通過訪問我們的收益增長報告評估 Blade Air Mobility 的前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis"/></p>
<p>NasdaqCM:BLDE 財務狀況分析截至 2025 年 5 月</p>
<h2>Cardlytics (NasdaqGM:CDLX)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Cardlytics, Inc. 在美國和英國運營一個廣告平台，市值約為 9.6 億美元。</p>
<p><strong>運營：</strong> 該公司的收入主要來自其 Cardlytics 平台，產生了 2.5562 億美元，以及其 Bridg 平台，貢獻了 2268 萬美元。</p>
<p><strong>市值：</strong> 9.6 億美元</p>
<p>Cardlytics, Inc. 面臨挑戰，仍處於虧損狀態，2024 年淨虧損為 1.893 億美元，較前一年的虧損有所擴大。儘管相對價值良好，且短期資產為 1.78 億美元，覆蓋了短期和長期負債，但其 211.4% 的高淨債務與股本比率引發了對財務槓桿的擔憂。該公司最近修訂了貸款協議，將到期日延長至 2028 年，且沒有借入額外資金，保持了 6000 萬美元的可用信貸。2025 年第一季度的收入指引設定在 5700 萬至 6000 萬美元之間，表明在運營波動中收入壓力持續。</p>
<ul>
<li>解鎖我們對 Cardlytics 股票分析的全面見解，查看此財務健康報告。</li>
<li>通過檢查我們的增長報告瞭解 Cardlytics 的收益前景。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:CDLX 收入與支出分析截至 2025 年 5 月</p>
<h2>Douglas Elliman (NYSE:DOUG)</h2>
<p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
<p><strong>概述：</strong> Douglas Elliman Inc. 在美國的房地產服務和物業技術投資領域運營，市值約為 1.6222 億美元。</p>
<p><strong>運營：</strong> 該公司的收入主要來自美國的房地產服務和物業技術投資，總額為 10.5 億美元。</p>
<p><strong>市值：</strong> 1.6222 億美元</p>
<p>Douglas Elliman Inc. 的市值為 1.6222 億美元，報告收入為 10.5 億美元，但仍處於虧損狀態，股本回報率為負（-25.61%）。儘管 2025 年第一季度收入較去年增加至 2.534 億美元，但公司錄得淨虧損 599 萬美元，雖然較之前的虧損有所改善，但對於關注盈利能力的投資者來説仍然令人擔憂。公司的短期資產超過其短期負債，提供了一定的財務穩定性；然而，長期負債仍未被這些資產覆蓋，突顯出在其通過近期的貨架註冊申請和收益電話會議努力穩定運營的過程中潛在的風險。</p>
<ul>
<li>點擊這裏查看完整的分析健康報告，以深入瞭解 Douglas Elliman。</li>
<li>通過我們關於公司歷史業績的報告，獲取 Douglas Elliman 過去趨勢和表現的洞察。</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown"/></p>
<p>截至 2025 年 5 月 NYSE:DOUG 收入與支出明細</p>
<h2>總結</h2>
<ul>
<li>在這裏探索我們美國便士股票篩選器中的 748 個名稱。</li>
<li>準備好採取不同的方法了嗎？尋找現金流潛力良好但交易價格低於公允價值的公司。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
<p>如果您想交易 Cardlytics，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
<p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
<p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的費用。</p>
<p>贊助內容</p>

DOUG

BLDE

SRTA

<p>美國市場在過去一週上漲了 2.8%，在過去一年中上漲了 9.3%，預計年收益增長將達到 14%。在這一增長中，財務狀況良好的低價股受到關注，包括 Blade Air Mobility、Cardlytics 和 Douglas Elliman，儘管面臨挑戰，但各自展現出獨特的機會。Blade Air Mobility 的市值為 2.3427 億美元，且沒有債務；Cardlytics 的市值為 9.6 億美元，但面臨盈利問題。Douglas Elliman 的市值為 1.6222 億美元，報告收入為 10.5 億美元，但仍處於虧損狀態。投資者被鼓勵探索這些股票，以尋找潛在的價值和增長</p>

<p>Over the last 7 days, the United States market has risen 2.8%, and over the past 12 months, it is up 9.3%, with earnings forecasted to grow by 14% annually. In such a climate, identifying stocks with strong financials becomes crucial for those seeking value and growth potential. Penny stocks, though often considered niche due to their smaller size or newer status, can present unique opportunities when they demonstrate robust financial health and long-term promise.</p>
<div class="lb-trans"><p>在過去的 7 天裏，美國市場上漲了 2.8%，在過去 12 個月中上漲了 9.3%，預計年收益將增長 14%。在這樣的環境下，識別財務狀況良好的股票對於尋求價值和增長潛力的投資者來説變得至關重要。雖然便士股票由於其較小的規模或較新的狀態常被視為小眾，但當它們展現出強健的財務健康和長期前景時，仍然可以提供獨特的機會。</p>
</div><h3>Top 10 Penny Stocks In The United States</h3>
<div class="lb-trans"><h3>美國十大便士股票</h3>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Name</strong></td>
<td><strong>Share Price</strong></td>
<td><strong>Market Cap</strong></td>
<td><strong>Rewards &amp; Risks</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.45</td>
<td>$361.71M</td>
<td>✅ 4 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.39</td>
<td>$1.44B</td>
<td>✅ 3 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Perfect (NYSE:PERF)</td>
<td>$1.86</td>
<td>$189.44M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.05</td>
<td>$18.66M</td>
<td>✅ 4 ⚠️ 4 View Analysis &gt;</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.315</td>
<td>$9.95M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.65</td>
<td>$46.16M</td>
<td>✅ 4 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>Imperial Petroleum (NasdaqCM:IMPP)</td>
<td>$2.56</td>
<td>$77.65M</td>
<td>✅ 3 ⚠️ 1 View Analysis &gt;</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8294</td>
<td>$6.02M</td>
<td>✅ 2 ⚠️ 3 View Analysis &gt;</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.594</td>
<td>$80.24M</td>
<td>✅ 3 ⚠️ 2 View Analysis &gt;</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.7957</td>
<td>$71.73M</td>
<td>✅ 4 ⚠️ 1 View Analysis &gt;</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>名稱</strong></td>
<td><strong>股價</strong></td>
<td><strong>市值</strong></td>
<td><strong>收益與風險</strong></td>
</tr>
<tr>
<td>Safe Bulkers (NYSE:SB)</td>
<td>$3.45</td>
<td>$361.71M</td>
<td>✅ 4 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Tuya (NYSE:TUYA)</td>
<td>$2.39</td>
<td>$1.44B</td>
<td>✅ 3 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Perfect (NYSE:PERF)</td>
<td>$1.86</td>
<td>$189.44M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Smith Micro Software (NasdaqCM:SMSI)</td>
<td>$1.05</td>
<td>$18.66M</td>
<td>✅ 4 ⚠️ 4 查看分析</td>
</tr>
<tr>
<td>Kiora Pharmaceuticals (NasdaqCM:KPRX)</td>
<td>$3.315</td>
<td>$9.95M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>Flexible Solutions International (NYSEAM:FSI)</td>
<td>$3.65</td>
<td>$46.16M</td>
<td>✅ 4 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>Imperial Petroleum (NasdaqCM:IMPP)</td>
<td>$2.56</td>
<td>$77.65M</td>
<td>✅ 3 ⚠️ 1 查看分析</td>
</tr>
<tr>
<td>BAB (OTCPK:BABB)</td>
<td>$0.8294</td>
<td>$6.02M</td>
<td>✅ 2 ⚠️ 3 查看分析</td>
</tr>
<tr>
<td>Lifetime Brands (NasdaqGS:LCUT)</td>
<td>$3.594</td>
<td>$80.24M</td>
<td>✅ 3 ⚠️ 2 查看分析</td>
</tr>
<tr>
<td>CBAK Energy Technology (NasdaqCM:CBAT)</td>
<td>$0.7957</td>
<td>$71.73M</td>
<td>✅ 4 ⚠️ 1 查看分析</td>
</tr>
</tbody>
</table>
</div><p>Click here to see the full list of 748 stocks from our US Penny Stocks screener.</p>
<div class="lb-trans"><p>點擊這裏查看我們美國便士股票篩選器的 748 只股票完整列表。</p>
</div><p>We're going to check out a few of the best picks from our screener tool.</p>
<div class="lb-trans"><p>我們將查看篩選工具中一些最佳選擇。</p>
</div><h2>Blade Air Mobility (NasdaqCM:BLDE)</h2>
<div class="lb-trans"><h2>Blade Air Mobility (NasdaqCM:BLDE)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★★☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★★☆</p>
</div><p><strong>Overview:</strong> Blade Air Mobility, Inc. offers air transportation and logistics services for hospitals both in the United States and internationally, with a market cap of $234.27 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Blade Air Mobility, Inc. 提供美國及國際醫院的空中運輸和物流服務，市值為 2.3427 億美元。</p>
</div><p><strong>Operations:</strong> The company generates revenue from two main segments: Medical services, which contributed $146.82 million, and Passenger services, which brought in $101.88 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司主要通過兩個部門產生收入：醫療服務貢獻了 1.4682 億美元，乘客服務帶來了 1.0188 億美元。</p>
</div><p><strong>Market Cap:</strong> $234.27M</p>
<div class="lb-trans"><p><strong>市值：</strong> 2.3427 億美元</p>
</div><p>Blade Air Mobility, Inc. has shown resilience despite being currently unprofitable, with a net loss of US$27.31 million for 2024, an improvement from the previous year's US$56.08 million loss. The company benefits from a robust financial position with no debt and short-term assets of US$160.7 million exceeding liabilities significantly, providing a cash runway for over three years based on free cash flow. Recent initiatives include a pilot program in partnership with Skyports Infrastructure aimed at expanding urban air mobility services in New York City, potentially enhancing future revenue streams and operational efficiencies as they transition to electric vertical aircraft operations.</p>
<div class="lb-trans"><p>儘管目前處於虧損狀態，Blade Air Mobility, Inc. 仍展現出韌性，2024 年淨虧損為 2731 萬美元，較去年 5608 萬美元的虧損有所改善。該公司享有強健的財務狀況，沒有債務，短期資產為 1.607 億美元，遠超負債，為基於自由現金流提供了超過三年的現金流。近期的舉措包括與 Skyports Infrastructure 合作的試點項目，旨在擴大紐約市的城市空中出行服務，可能增強未來的收入來源和運營效率，隨着其向電動垂直起降飛機的過渡。</p>
</div><ul>
<li>Dive into the specifics of Blade Air Mobility here with our thorough balance sheet health report.</li>
<li>Evaluate Blade Air Mobility's prospects by accessing our earnings growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏深入瞭解 Blade Air Mobility 的具體情況，查看我們的詳細資產負債表健康報告。</li>
<li>通過訪問我們的收益增長報告評估 Blade Air Mobility 的前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis" alt="" original-src="https://images.simplywall.st/company/99908a6d-1565-4e53-a5d0-eb953ac60b00/chart/financial-position-analysis"/></p>
<p>NasdaqCM:BLDE Financial Position Analysis as at May 2025</p>
<div class="lb-trans"><p>NasdaqCM:BLDE 財務狀況分析截至 2025 年 5 月</p>
</div><h2>Cardlytics (NasdaqGM:CDLX)</h2>
<div class="lb-trans"><h2>Cardlytics (NasdaqGM:CDLX)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom, with a market cap of approximately $960 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Cardlytics, Inc. 在美國和英國運營一個廣告平台，市值約為 9.6 億美元。</p>
</div><p><strong>Operations:</strong> The company's revenue is primarily derived from its Cardlytics Platform, generating $255.62 million, and its Bridg Platform, contributing $22.68 million.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自其 Cardlytics 平台，產生了 2.5562 億美元，以及其 Bridg 平台，貢獻了 2268 萬美元。</p>
</div><p><strong>Market Cap:</strong> $96M</p>
<div class="lb-trans"><p><strong>市值：</strong> 9.6 億美元</p>
</div><p>Cardlytics, Inc. faces challenges as it remains unprofitable with a net loss of US$189.3 million for 2024, widening from the prior year's loss. Despite trading at good relative value and having short-term assets of US$178 million covering both short- and long-term liabilities, its high net debt to equity ratio of 211.4% raises concerns about financial leverage. The company recently amended its loan facility extending maturity to 2028 without borrowing additional funds, maintaining US$60 million in available credit. Revenue guidance for Q1 2025 is set between US$57-60 million, indicating continued revenue pressures amidst operational volatility.</p>
<div class="lb-trans"><p>Cardlytics, Inc. 面臨挑戰，仍處於虧損狀態，2024 年淨虧損為 1.893 億美元，較前一年的虧損有所擴大。儘管相對價值良好，且短期資產為 1.78 億美元，覆蓋了短期和長期負債，但其 211.4% 的高淨債務與股本比率引發了對財務槓桿的擔憂。該公司最近修訂了貸款協議，將到期日延長至 2028 年，且沒有借入額外資金，保持了 6000 萬美元的可用信貸。2025 年第一季度的收入指引設定在 5700 萬至 6000 萬美元之間，表明在運營波動中收入壓力持續。</p>
</div><ul>
<li>Unlock comprehensive insights into our analysis of Cardlytics stock in this financial health report.</li>
<li>Understand Cardlytics' earnings outlook by examining our growth report.</li>
</ul>
<div class="lb-trans"><ul>
<li>解鎖我們對 Cardlytics 股票分析的全面見解，查看此財務健康報告。</li>
<li>通過檢查我們的增長報告瞭解 Cardlytics 的收益前景。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/38c869b0-98c8-45b4-828e-ac89404e8e16/chart/revenue-and-expenses-breakdown"/></p>
<p>NasdaqGM:CDLX Revenue &amp; Expenses Breakdown as at May 2025</p>
<div class="lb-trans"><p>NasdaqGM:CDLX 收入與支出分析截至 2025 年 5 月</p>
</div><h2>Douglas Elliman (NYSE:DOUG)</h2>
<div class="lb-trans"><h2>Douglas Elliman (NYSE:DOUG)</h2>
</div><p><strong>Simply Wall St Financial Health Rating:</strong> ★★★★☆☆</p>
<div class="lb-trans"><p><strong>Simply Wall St 財務健康評級：</strong> ★★★★☆☆</p>
</div><p><strong>Overview:</strong> Douglas Elliman Inc. operates in the real estate services and property technology investment sectors in the United States, with a market cap of approximately $162.22 million.</p>
<div class="lb-trans"><p><strong>概述：</strong> Douglas Elliman Inc. 在美國的房地產服務和物業技術投資領域運營，市值約為 1.6222 億美元。</p>
</div><p><strong>Operations:</strong> The company generates its revenue primarily from real estate services and property technology investments in the United States, amounting to $1.05 billion.</p>
<div class="lb-trans"><p><strong>運營：</strong> 該公司的收入主要來自美國的房地產服務和物業技術投資，總額為 10.5 億美元。</p>
</div><p><strong>Market Cap:</strong> $162.22M</p>
<div class="lb-trans"><p><strong>市值：</strong> 1.6222 億美元</p>
</div><p>Douglas Elliman Inc. operates with a market cap of US$162.22 million and reported revenues of US$1.05 billion, yet remains unprofitable with a negative return on equity (-25.61%). Despite an increase in revenue to US$253.4 million for Q1 2025 from the previous year, the company recorded a net loss of US$5.99 million, an improvement from prior losses but still concerning for investors focused on profitability. The company's short-term assets exceed its short-term liabilities, providing some financial stability; however, long-term liabilities remain uncovered by these assets, highlighting potential risks amidst its ongoing efforts to stabilize operations through recent shelf registration filings and earnings calls.</p>
<div class="lb-trans"><p>Douglas Elliman Inc. 的市值為 1.6222 億美元，報告收入為 10.5 億美元，但仍處於虧損狀態，股本回報率為負（-25.61%）。儘管 2025 年第一季度收入較去年增加至 2.534 億美元，但公司錄得淨虧損 599 萬美元，雖然較之前的虧損有所改善，但對於關注盈利能力的投資者來説仍然令人擔憂。公司的短期資產超過其短期負債，提供了一定的財務穩定性；然而，長期負債仍未被這些資產覆蓋，突顯出在其通過近期的貨架註冊申請和收益電話會議努力穩定運營的過程中潛在的風險。</p>
</div><ul>
<li>Jump into the full analysis health report here for a deeper understanding of Douglas Elliman.</li>
<li>Gain insights into Douglas Elliman's past trends and performance with our report on the company's historical track record.</li>
</ul>
<div class="lb-trans"><ul>
<li>點擊這裏查看完整的分析健康報告，以深入瞭解 Douglas Elliman。</li>
<li>通過我們關於公司歷史業績的報告，獲取 Douglas Elliman 過去趨勢和表現的洞察。</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown" alt="" original-src="https://images.simplywall.st/company/18cf184e-9e5e-4190-9725-3c35ea89f9a7/chart/revenue-and-expenses-breakdown"/></p>
<p>NYSE:DOUG Revenue &amp; Expenses Breakdown as at May 2025</p>
<div class="lb-trans"><p>截至 2025 年 5 月 NYSE:DOUG 收入與支出明細</p>
</div><h2>Summing It All Up</h2>
<div class="lb-trans"><h2>總結</h2>
</div><ul>
<li>Explore the 748 names from our US Penny Stocks screener here.</li>
<li>Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.</li>
</ul>
<div class="lb-trans"><ul>
<li>在這裏探索我們美國便士股票篩選器中的 748 個名稱。</li>
<li>準備好採取不同的方法了嗎？尋找現金流潛力良好但交易價格低於公允價值的公司。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，採用無偏見的方法，我們的文章不構成財務建議。</strong> 這並不構成買入或賣出任何股票的推薦，也未考慮您的目標或財務狀況。我們的目標是為您提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div><p>If you're looking to trade Cardlytics, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.</p>
<div class="lb-trans"><p>如果您想交易 Cardlytics，請在專業人士信賴的最低成本平台 Interactive Brokers 開設賬户。</p>
</div><p>With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.</p>
<div class="lb-trans"><p>IBKR 在 200 多個國家和地區擁有客户，並可訪問 160 個市場，讓您可以通過一個集成賬户交易股票、期權、期貨、外匯、債券和基金。</p>
</div><p>Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.</p>
<div class="lb-trans"><p>享受無隱藏費用，無賬户最低要求，外匯轉換率低至 0.03%，遠低於大多數經紀商提供的費用。</p>
</div><p>Sponsored Content</p>
<div class="lb-trans"><p>贊助內容</p>
</div>

3 只市值超過 9000 萬美元的有潛力的便士股票